Nestle Puts Peanut-Allergy Treatment Palforzia Up for Sale, Bloomberg Reports
02 3월 2023 - 5:42PM
Dow Jones News
--Nestle SA has started a process to sell its peanut-allergy
treatment Palforzia, Bloomberg reports, citing unnamed sources.
--Initial bids are expected next month, but no final decision
has been made on the timing of any sale, Bloomberg reports.
--Nestle, which bought the maker of Palforzia in a $2.6 billion
deal in 2020 and recently announced a $2.1 billion impairment
charge on the medication, declined to comment.
Full story: https://bloom.bg/3y2fmuv
Write to Adria Calatayud at adria.calatayud@dowjones.com
(END) Dow Jones Newswires
March 02, 2023 03:27 ET (08:27 GMT)
Copyright (c) 2023 Dow Jones & Company, Inc.
Nestle (PK) (USOTC:NSRGY)
과거 데이터 주식 차트
부터 4월(4) 2024 으로 5월(5) 2024
Nestle (PK) (USOTC:NSRGY)
과거 데이터 주식 차트
부터 5월(5) 2023 으로 5월(5) 2024
Nestle SA (PK) (OTC 시장)의 실시간 뉴스: 최근 기사 0
More Nestle SA (PK) News Articles